Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence in COVID-19 drug repurposing
Yadi Zhou, Fei Wang, Jian Tang, et al.
The Lancet Digital Health (2020) Vol. 2, Iss. 12, pp. e667-e676
Open Access | Times Cited: 535

Showing 1-25 of 535 citing articles:

Deep Learning applications for COVID-19
Connor Shorten, Taghi M. Khoshgoftaar, Borko Furht
Journal Of Big Data (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 300
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies
Alexandre Blanco-González, Alfonso Cabezón, Alejandro Seco-González, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 891-891
Open Access | Times Cited: 287
Artificial intelligence in cancer target identification and drug discovery
Yujie You, Xin Lai, Yi Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 202
Building a knowledge graph to enable precision medicine
Payal Chandak, Kexin Huang, Marinka Žitnik
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 172
Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review
Muzammil Khan, Muhammad Taqi Mehran, Zeeshan Haq, et al.
Expert Systems with Applications (2021) Vol. 185, pp. 115695-115695
Open Access | Times Cited: 163
Drug repurposing for COVID-19 via knowledge graph completion
Rui Zhang, Dimitar Hristovski, Dalton Schutte, et al.
Journal of Biomedical Informatics (2021) Vol. 115, pp. 103696-103696
Open Access | Times Cited: 160
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
PLoS Biology (2020) Vol. 18, Iss. 11, pp. e3000970-e3000970
Open Access | Times Cited: 159
Robotics and artificial intelligence in healthcare during COVID-19 pandemic: A systematic review
Sujan Sarker, Lafifa Jamal, Syeda Faiza Ahmed, et al.
Robotics and Autonomous Systems (2021) Vol. 146, pp. 103902-103902
Open Access | Times Cited: 152
A definition, benchmark and database of AI for social good initiatives
Josh Cowls, Andreas Tsamados, Mariarosaria Taddeo, et al.
Nature Machine Intelligence (2021) Vol. 3, Iss. 2, pp. 111-115
Open Access | Times Cited: 136
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Deep generative molecular design reshapes drug discovery
Xiangxiang Zeng, Fei Wang, Yuan Luo, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100794-100794
Open Access | Times Cited: 131
Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework
Xiangxiang Zeng, Hongxin Xiang, Linhui Yu, et al.
Nature Machine Intelligence (2022) Vol. 4, Iss. 11, pp. 1004-1016
Open Access | Times Cited: 130
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Yan Ling Ng, Cyrill Kafi Salim, Justin Jang Hann Chu
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107930-107930
Open Access | Times Cited: 129
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 128-139
Open Access | Times Cited: 124
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 2, pp. 249-258
Open Access | Times Cited: 114
The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic
Francesco Piccialli, Vincenzo Schiano Di Cola, Fabio Giampaolo, et al.
Information Systems Frontiers (2021) Vol. 23, Iss. 6, pp. 1467-1497
Open Access | Times Cited: 109
Drug combination therapy for emerging viral diseases
Zeenat A. Shyr, Yu‐Shan Cheng, Donald C. Lo, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2367-2376
Open Access | Times Cited: 109
Crisis as opportunity, disruption and exposure: Exploring emergent responses to crisis through digital technology
Manos Gkeredakis, Hila Lifshitz‐Assaf, Michael Barrett
Information and Organization (2021) Vol. 31, Iss. 1, pp. 100344-100344
Closed Access | Times Cited: 105
AlphaFold, Artificial Intelligence (AI), and Allostery
Ruth Nussinov, Mingzhen Zhang, Yonglan Liu, et al.
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 34, pp. 6372-6383
Open Access | Times Cited: 103
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 96
The metaverse in current digital medicine
Mengting Sun, Linshan Xie, Yang Liu, et al.
Clinical eHealth (2022) Vol. 5, pp. 52-57
Closed Access | Times Cited: 84
The Ethics of Artificial Intelligence
Luciano Floridi
Oxford University Press eBooks (2023)
Closed Access | Times Cited: 73
Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
Sali Abubaker Bagabir, Nahla Khamis Ibrahim, Hala Abubaker Bagabir, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 289-296
Open Access | Times Cited: 69
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
Anita Ioana Visan, Irina Neguț
Life (2024) Vol. 14, Iss. 2, pp. 233-233
Open Access | Times Cited: 69
Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers
Dongmin Bang, Sangsoo Lim, Sangseon Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top